Iron Dome and Arrow Producers Move Toward Public Markets as Listing Disputes Drag On
Rafael and IAI, makers of Iron Dome and Arrow, are pursuing IPOs, but regulatory and structural disputes are slowing the process.
Two of Israel’s most prominent state-owned defense manufacturers — Rafael Advanced Defense Systems, maker of the Iron Dome interceptor system, and Israel Aerospace Industries, which produces the Arrow ballistic missile defense system — are advancing plans for initial public offerings, according to Calcalist Tech. The moves would represent a significant structural shift for companies whose products have become central to layered air defense architectures both domestically and among allied export customers. Readers following the Arrow program’s recent development arc can find additional context in GDD’s earlier coverage of Arrow missile defense.
The IPO push comes as both companies carry heightened strategic profiles following years of operational demand. Iron Dome has intercepted thousands of short-range rockets and projectiles, while Arrow has been employed against longer-range ballistic threats, including Iranian-origin missiles. The combination of proven combat records and sustained procurement pipelines gives both firms the revenue visibility that equity markets typically require before a listing can proceed.
Competing Jurisdictions and Structural Hurdles
Despite investor interest, the path to market is complicated. According to the Calcalist Tech report, disputes remain over where and how the companies should list — including questions about which stock exchange would host the offerings and how state ownership stakes would be structured post-IPO. Israel’s government retains controlling interests in both Rafael and IAI, and any public offering must navigate restrictions tied to that ownership, as well as national-security sensitivities surrounding the companies’ core technology portfolios.
The report notes that the listing process has drawn competing positions from Israeli government ministries and financial regulators, each with differing views on valuation methodology, the pace of the offering, and the degree to which sensitive defense business units should be ring-fenced from public-shareholder scrutiny. Those disagreements have extended the pre-IPO timeline without a resolution date disclosed in the reporting. Officials have not confirmed a target listing date for either company.
Industrial Scale and Market Implications
Both Rafael and IAI operate at considerable industrial scale. IAI is one of Israel’s largest exporters, with a product range that extends from satellites and unmanned systems to radar and electronic warfare platforms. Rafael’s portfolio spans precision-guided munitions, naval systems, and several interceptor families beyond Iron Dome. A successful IPO for either company would inject private capital into organizations that have historically relied on government funding and export contracts to finance research and production expansion.
The broader defense-industry context matters here. Western governments and their allies have accelerated procurement of air and missile defense systems since 2022, driving order backlogs at producers across the sector. That demand environment could support premium valuations for both firms — but it also means their production capacity is already under pressure, a factor that equity analysts would need to weigh when modeling forward earnings. How the Israeli government ultimately resolves the structural and jurisdictional disputes outlined in the Calcalist Tech report will likely determine whether either IPO moves to market in the near term or remains on an extended preparatory track. The broader question of defense-sector financing is one GDD has tracked in related industrial contexts, including the dynamics facing Israeli AI chip developers seeking outside capital.
